Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Genitourinary Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Genitourinary Drugsmarket, defines the market attractiveness level of Genitourinary Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Genitourinary Drugs industry, describes the types of Genitourinary Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Genitourinary Drugs market and the development prospects and opportunities of Genitourinary Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Genitourinary Drugs market in Chapter 13.
By Player:
Novartis AG
Genentech
By Type:
Urologicals
Hormonal Therapy
Gynecological
Anti-infectives
By End-User:
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Urinary Incontinence & Overactive Bladder
Sexually Transmitted Diseases
Interstitial Cystitis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Genitourinary Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Genitourinary Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Genitourinary Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Genitourinary Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Genitourinary Drugs Market Analysis and Outlook to 2022
-
7.1 Global Genitourinary Drugs Consumption (2017-2022)
-
7.2 United States Genitourinary Drugs Consumption (2017-2022)
-
7.3 Europe Genitourinary Drugs Consumption (2017-2022)
-
7.4 China Genitourinary Drugs Consumption (2017-2022)
-
7.5 Japan Genitourinary Drugs Consumption (2017-2022)
-
7.6 India Genitourinary Drugs Consumption (2017-2022)
-
7.7 South Korea Genitourinary Drugs Consumption (2017-2022)
8 Region and Country-wise Genitourinary Drugs Market Analysis and Outlook to 2028
-
8.1 Global Genitourinary Drugs Consumption Forecast (2022-2028)
-
8.2 United States Genitourinary Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Genitourinary Drugs Consumption Forecast (2022-2028)
-
8.4 China Genitourinary Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Genitourinary Drugs Consumption Forecast (2022-2028)
-
8.6 India Genitourinary Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Genitourinary Drugs Consumption Forecast (2022-2028)
9 Global Genitourinary Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Genitourinary Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Urologicals Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gynecological Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anti-infectives Consumption and Growth Rate (2017-2022)
-
9.2 Global Genitourinary Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cervical Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Renal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Urinary Tract Infections Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Urinary Incontinence & Overactive Bladder Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Sexually Transmitted Diseases Consumption and Growth Rate (2017-2022)
-
9.2.10 Global Interstitial Cystitis Consumption and Growth Rate (2017-2022)
10 Global Genitourinary Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Genitourinary Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Urologicals Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Gynecological Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anti-infectives Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Genitourinary Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Renal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Urinary Tract Infections Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Urinary Incontinence & Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.9 Global Sexually Transmitted Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.10 Global Interstitial Cystitis Consumption Forecast and Growth Rate (2022-2028)
11 Global Genitourinary Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Genitourinary Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Genitourinary Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Genitourinary Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Genitourinary Drugs Market Competitive Analysis
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Details
-
14.1.2 Novartis AG Genitourinary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG Genitourinary Drugs Product and Service
-
14.2 Genentech
-
14.2.1 Genentech Company Details
-
14.2.2 Genentech Genitourinary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genentech Genitourinary Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Genitourinary Drugs
-
Figure Genitourinary Drugs Picture
-
Table Global Genitourinary Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Genitourinary Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Genitourinary Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Genitourinary Drugs Consumption by Country (2017-2022)
-
Figure United States Genitourinary Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Genitourinary Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Genitourinary Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Genitourinary Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Genitourinary Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Genitourinary Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Genitourinary Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Genitourinary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Genitourinary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Genitourinary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Genitourinary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Genitourinary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Genitourinary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urologicals Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Gynecological Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-infectives Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)
-
Figure Global Urinary Tract Infections Consumption and Growth Rate (2017-2022)
-
Figure Global Urinary Incontinence & Overactive Bladder Consumption and Growth Rate (2017-2022)
-
Figure Global Sexually Transmitted Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Interstitial Cystitis Consumption and Growth Rate (2017-2022)
-
Figure Global Urologicals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gynecological Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-infectives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urinary Tract Infections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urinary Incontinence & Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sexually Transmitted Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interstitial Cystitis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Genitourinary Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Genitourinary Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Genitourinary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Genitourinary Drugs Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Genitourinary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Genitourinary Drugs Product and Service
-
